Diabetes drug may elevate bladder cancer risk
Toronto, July 4 (IANS) Pioglitazone, a drug commonly prescribed for type 2 diabetes, may also elevate bladder cancer risk, says a new Canadian research.
In a bid to link pioglitazone and bladder cancer, researchers conducted a systematic review and analysis of clinical trials and observational studies involving over 2.6 million patients.
"We observed an increased risk of bladder cancer associated with the use of thiazolidinediones," writes Jeffrey Johnson from the School of Public Health, University of Alberta and study co-author, the Canadian Medical Association Journal reports.
Thiazolidinediones, including Pioglitazone, introduced in the late 1990s, are also known as glitazones, a class of drugs used in the treatment of type 2 diabetes, according to an Alberta statement.
"In particular, use of pioglitazone was associated with an increased risk of bladder cancer based on a pooled estimate from three cohort studies involving more than 1.7 million individuals," adds Johnson.
The researchers also looked at a possible association with rosiglitazone, another type of thiazolidinedione, but did not see an effect.
Read More: Union Public Service Commissio | Public Service Commission | B.r.d Medical College | Mlb Medical College So | Medical Campus | Public Office | Gandhi Medical College | Hyderabad Public School | Guntur Medical College | St. John's Medical College | Ponneri Public Office | Chengalpattu Public Offices | Cuddalore Public Offices | Papanasam Public Office | Ramnanathapuram Public Offices | Periyakulam Public Office | M.g.m Medical College | Ranchi Medical College | Ranchi Medical College Campus | Khuda Bakhsh Oriental Public Library
4TH C V RAMAN INT'L FELLOWSHIP LAUNCHED FOR RESEARCH
May 21, 2013 at 10:07 PM
WE WILL BRING A NEW LAW TO REGULATE FIXING : JITENDRA SINGH
May 21, 2013 at 10:00 PM
COURT ALLOWS FIVE DAY POLICE CUSTODY FOR THE IPL FIXERS
May 21, 2013 at 9:58 PM